ExitValue.ai

M&A TRANSACTION · 2026

Unbound Medicine acquired by MPS Ltd

$16.5M· Healthcare IT

Target

Unbound Medicine

Acquirer

MPS Ltd

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$8.9M

EBITDA

-

Deal Value

$16.5M

What's your healthcare it worth today?

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

  • Sellability score with 5-driver breakdown and lift estimates
  • Named comparable M&A transactions in your sub-vertical
  • AI-written analysis grounded in your specific inputs
Run my valuation analysis →

Context

This $16.5M acquisition of Unbound Medicine by MPS Ltd sits in the healthcare it sub-vertical. Run a valuation for your own healthcare it business via our Healthcare IT valuation hub. MPS Ltd is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare IT strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

  • Sellability score with 5-driver breakdown and lift estimates
  • Named comparable M&A transactions in your sub-vertical
  • AI-written analysis grounded in your specific inputs
Run my valuation analysis →

Compare your business to the Unbound Medicine acquisition.

More on healthcare it valuations

Citation: ExitValue.ai. (2026). Unbound Medicine acquired by MPS Ltd. https://exitvalue.ai/deals/unbound-medicine-acquired-by-mps-ltd-hc-2026-0001